05Aug2025

39% US Tariffs on Swiss Goods 💥

Disclaimer: The views and opinions expressed in the vapa Swiss independent wealth management blog posts featured on this page are solely my own and do not necessarily represent the views of any institutions or organisations I may be associated with. These posts are intended to share personal insights and perspectives and should not be interpreted as official statements or positions of any affiliated entities.

– A Headache for Exporters, a Signal for Wealth Managers

The US has announced tariffs of up to 39% on Swiss exports, taking effect on 7 August 2025. Watches, industrial machinery, and premium products are on the list — and markets are watching closely.

The move doesn’t target financial services directly. But portfolio exposure is another matter.

Export-heavy Swiss companies like Swatch, Richemont, Bucher, or Stadler may face margin pressure if US demand reacts. These names often appear in equity portfolios, global funds, or ETFs — sometimes without being obvious.

What’s Exempt (For Now)

Meanwhile, two major sectors remain exempt (for now): 🔹 Pharmaceuticals — including Roche and Novartis 🔹 Gold and precious metals

So not everything is affected — but enough to warrant a closer look at sector allocation and portfolio composition.

Why This Still Matters for Wealth Managers

Independent wealth managers may not feel this 39% tariff directly, but clients will ask questions. And in times of uncertainty, how information is framed matters just as much as what is said.

This isn’t a compliance issue. It’s a visibility issue.

Clients don’t expect you to solve geopolitics.

💬 How are you positioning portfolios around Swiss export exposure?

Source: LinkedIn

No votes yet.
Please wait...
Illustration showing Swiss-made goods facing a 39% US tariff, with watch, gear, and export barrier

Get Your Monthly Insights!

* indicates required


Please select all the ways you would like to hear from vapa.ch:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.